Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine

This study is currently recruiting participants.
Verified July 2010 by University of Bergen
Sponsor:
Information provided by:
University of Bergen
ClinicalTrials.gov Identifier:
NCT00995332
First received: October 14, 2009
Last updated: June 9, 2011
Last verified: July 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2015
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)